RUPERTO NICOLINO
Publications
La Bella, S., Alongi, A., Filocamo, G., Cattalini, M., Lanni, S., Marino, A., et al. (2026). Environmental determinants of juvenile idiopathic arthritis: current evidence and future directions. GLOBAL PEDIATRICS, 16(June 2026) [10.1016/j.gpeds.2026.100336]. Detail
Ramanan, A., Ruperto, N., Foeldvari, I., Vega-Cornejo, G., Keller, S., Wang, R., et al. (2026). Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab. THE LANCET. RHEUMATOLOGY, 8(5), 377-388 [10.1016/S2665-9913(25)00346-7]. Detail
La Bella, S., Rebollo-Giménez, A., Aouad, K., Gupta, L., Kragstrup, T., Bayraktar, D., et al. (2026). Artificial intelligence in rheumatology and paediatric rheumatology: insights from an international survey by EMEUNET. EULAR RHEUMATOLOGY OPEN, 2(2 (June 2026)) [10.1016/j.ero.2026.03.001]. Detail
La Bella, S., Rebollo-Gimenez, A., Alongi, A., Capitoli, G., Breda, L., La Torre, F., et al. (2026). The role of artificial intelligence in clinical trials in adult and pediatric rheumatology. CURRENT OPINION IN IMMUNOLOGY, 102(October 2026) [10.1016/j.coi.2026.102818]. Detail
Mastrolia, M., Pandiarajan, V., Cattalini, M., Taddio, A., Vergnano, S., Anton, J., et al. (2026). Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study. ECLINICALMEDICINE, 93(March 2026) [10.1016/j.eclinm.2026.103813]. Detail